Publications

Abdulla, DSY, Scheffler, M, Brandes, V, Ruge, M, Kunze, S, Merkelbach-Bruse, S, Nogova, L, Michels, S, Fischer, R, Riedel, R, Büttner, R, Persigehl, T, Grau, S, Galldiks, N, Drzezga, A, Kobe, C, and Wolf, J. "Monitoring Treatment Response to Erlotinib in EGFR-mutated Non–small-cell Lung Cancer Brain Metastases Using Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET." Clinical Lung Cancer (November 2018).

Full Text

Madenci, AL, Weil, BR, Liu, Q, Murphy, AJ, Gibson, TM, Yasui, Y, Leisenring, WM, Howell, RM, Tinkle, CL, Nekhlyudov, L, Diller, LR, Armstrong, GT, Oeffinger, KC, and Weldon, CB. "Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study." Journal of Clinical Oncology 36, no. 31 (November 2018): 3144-3151.

Full Text

Vorren, K, Ge, Y, Kelley, MJ, Song, H, Wu, QRJ, and Salama, JK. "Modeling and Prediction of SIB Prostate IMRT Plans." 60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO). San Antonio, TX. October 21, 2018 - October 24, 2018.: ELSEVIER SCIENCE INC, November 1, 2018.

Full Text

Aminsharifi, A, Schulman, A, Anderson, J, Fish, L, Oeffinger, K, Shah, K, Sze, C, Tay, KJ, Tsivian, E, and Polascik, TJ. "Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record." Urologic Oncology 36, no. 11 (November 2018): 502.e1-502.e6.

PMID
30170982
Full Text

Graham, CN, Christodoulopoulou, A, Knox, HN, Sabatelli, L, Hechmati, G, Garawin, T, and Strickler, JH. "A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-type RAS metastatic colorectal cancer in the US." Journal of Medical Economics 21, no. 11 (November 2018): 1075-1083.

PMID
30091652
Full Text

Choueiri, TK, Hessel, C, Halabi, S, Sanford, B, Michaelson, MD, Hahn, O, Walsh, M, Olencki, T, Picus, J, Small, EJ, Dakhil, S, Feldman, DR, Mangeshkar, M, Scheffold, C, George, D, and Morris, MJ. "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125]." European Journal of Cancer (Oxford, England : 1990) 103 (November 2018): 287-null.

PMID
30270112
Full Text

Xu, Y, Liu, H, Liu, S, Wang, Y, Xie, J, Stinchcombe, TE, Su, L, Zhang, R, Christiani, DC, Li, W, and Wei, Q. "Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer." International Journal of Cancer 143, no. 10 (November 2018): 2400-2408.

PMID
29978465
Full Text

Thompson, EM, Landi, D, Ashley, D, Keir, ST, and Bigner, D. "Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status." Journal of Neuro Oncology 140, no. 2 (November 2018): 261-268.

PMID
30120661
Full Text

Tovmasyan, A, Bueno-Janice, JC, Jaramillo, MC, Sampaio, RS, Reboucas, JS, Kyui, N, Benov, L, Deng, B, Huang, T-T, Tome, ME, Spasojevic, I, and Batinic-Haberle, I. "Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate." Antioxidants & Redox Signaling 29, no. 13 (November 2018): 1196-1214.

PMID
29390861
Full Text

Kane, A, Thorpe, MP, Morse, MA, Howard, BA, Oldan, JD, Zhu, J, Wong, TZ, Petry, NA, Reiman, R, and Borges-Neto, S. "Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 59, no. 11 (November 2018): 1708-1713.

PMID
29777005
Full Text

Pages